Evidence map›Paper›PMID 29152229›Full record

ReviewF1000Research2017

Ticking time bombs: connections between circadian clocks and cancer.

Katja A Lamia

Open access · goldAbstract readReview
In one paragraph

Review in F1000Research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Shift Work and Prostate Cancer: An Updated Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Distribution of sleep components while working remotely.International journal of occupational medicine and environmental health · 2024
    Article
  8. Light at night and lung cancer risk: A worldwide interdisciplinary and time-series study.Chinese medical journal pulmonary and critical care medicine · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Circadian regulation of c-MYC in mice.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Cancer, hear my battle CRY.Journal of pineal research · 2020
    Review
  20. A tail of CRY selectivity.Nature chemical biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Katja A LamiaDepartment of Molecular Medicine, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA, 92037, USA.ORCID https://orcid.org/0000-0001-9533-0499
Scripps Research Institute · US

Funding

Impacting Cell Growth through altered circadian proteolysisR01CA211187 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI Katja A Lamia · 2017 to 2026
$4.6M
Circadian molecular regulation of the xenobiotic responseR01DK097164 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI LAMIA, KATJA A · 2013 to 2017
$2.1M
NCI NIH HHS R01 CA211187NIDDK NIH HHS R01 DK097164
6 · The paper itself

Abstract

Connections between mammalian circadian and cell division cycles have been postulated since the early 20th century, and epidemiological and genetic studies have linked disruption of circadian clock function to increased risk of several types of cancer. In the past decade, it has become clear that circadian clock components influence cell growth and transformation in a cell-autonomous manner. Furthermore, several molecular mechanistic connections have been described in which clock proteins participate in sensing DNA damage, modulating DNA repair, and influencing the ubiquitination and degradation of key players in oncogenesis (c-MYC) and tumor suppression (p53).

Indexed as

cancercell cyclecircadian clockCRYsPERs

Identifiers

PMID29152229
PMCPMC5664980
OpenAlexW2766618226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.